4.6 Article

Epigenetic Regulation of Myofibroblast Differentiation by DNA Methylation

Journal

AMERICAN JOURNAL OF PATHOLOGY
Volume 177, Issue 1, Pages 21-28

Publisher

ELSEVIER SCIENCE INC
DOI: 10.2353/ajpath.2010.090999

Keywords

-

Categories

Funding

  1. National Institute of Health [HL28737, HL31963, HL52285, HL77297, HL91775]

Ask authors/readers for more resources

DNA methylation, a key mechanism of repressing gene expression, is of particular relevance in controlling development and cell differentiation. We analyzed the extent and regulation of DNA methylation of the a-smooth muscle actin (alpha-SMA) gene to elucidate its potential role in myofibroblast differentiation. These experiments revealed the presence of three CpG islands that were methylated at different levels in fibroblasts, myofibroblasts, and alveolar epithelial type H cells. Coordinately, these cells expressed low, high, or no a-SMA, respectively. In addition, inhibition of DNA methyltransferase activity or knock down of DNA methyltransferase using specific small interfering RNA caused significant induction of a-SMA in fibroblasts. In contrast, induced overexpression of DNA methyltransferase suppressed a-SMA gene expression. Transforming growth factor 13 induced myofibroblast differentiation was enhanced or suppressed by knockdown or overexpression of DNA methyltransferase, respectively. Finally, in vitro DNA methylation of the a-SMA promoter suppressed its activity. These findings suggest that DNA methylation mediated by DNA methyltransferase is an important mechanism regulating the a-SMA gene expression during myofibroblast differentiation. (Am J Pathol 2010, 177.21-28; DOI: 10.2353/ajpath.2010.090999)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available